L. Jones

发表

Genetic identification of familial hypercholesterolemia within a single U.S. health care system

Marylyn D. Ritchie, Alan R. Shuldiner, Laney K. Jones, 2016, Science.

Developing Pharmacogenomic Reports: Insights from Patients and Clinicians

Laney K. Jones, Audrey L. Fan, Marc S. Williams, 2018, Clinical and translational science.

International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia

Laney K. Jones, P. Libby, S. Yamashita, 2023, Nature Reviews Cardiology.

Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening

H. Kirchner, M. Oetjens, A. Sturm, 2023, Journal of the American Heart Association.

Understanding the Patient Experience of Receiving Clinically Actionable Genetic Results from the MyCode Community Health Initiative, a Population-Based Genomic Screening Initiative

Laney K. Jones, Cassandra J. Pisieczko, A. Sturm, 2022, Journal of personalized medicine.

Clinical outcomes of a genomic screening program for actionable genetic conditions

Laney K. Jones, Marc S. Williams, D. Ledbetter, 2020, Genetics in Medicine.

Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol.

Laney K. Jones, Marc S. Williams, R. Brownson, 2020, Research in social & administrative pharmacy : RSAP.

The importance of buprenorphine research in the opioid crisis

Laney K. Jones, S. Pendergrass, W. Berrettini, 2019, Molecular Psychiatry.

Hidden Burden of Electronic Health Record‐Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care

Laney K. Jones, Marc S. Williams, H. Kirchner, 2019, Journal of the American Heart Association.

Laney K. Jones, C. Ballantyne, A. Goldberg, 2022, Journal of clinical lipidology.

Population Genomic Screening for Three Common Hereditary Conditions

Laney K. Jones, J. Schildcrout, J. Peterson, 2023, Annals of Internal Medicine.

Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study

Laney K. Jones, A. Sturm, S. Savage, 2023, PEC innovation.

A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System

Laney K. Jones, Marc S. Williams, R. Glasgow, 2022, Frontiers in Genetics.

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol

Laney K. Jones, Katrina M. Romagnoli, Ilene G. Ladd, 2022, Journal of personalized medicine.

Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.

Laney K. Jones, Marc S. Williams, S. Gidding, 2020, PloS one.

Applying implementation science to improve care for familial hypercholesterolemia

Laney K. Jones, Marc S. Williams, R. Brownson, 2021, Current opinion in endocrinology, diabetes, and obesity.

Medication therapy disease management: Geisinger's approach to population health management.

Laney K. Jones, M. Murray, J. Graham, 2017, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

The impact of a hematopoietic cellular therapy pharmacist on clinical and humanistic outcomes: A RE-AIM framework analysis.

Laney K. Jones, L. Tusing, J. Lynch, 2022, Transplantation and cellular therapy.

An Innovative Patient-Centered, Multidisciplinary Approach for the Delivery of Genomic Sequencing Results and Pharmacist-Led Lipid Management to Patients With Familial Hypercholesterolemia

M. Murray, E. Wright, Mark Williams, 2016 .

Statin Intolerance: an Overview of US and International Guidance

Tyler J. Schubert, Mary Katherine Cheeley, K.D. Clegg, 2023, Current Atherosclerosis Reports.

Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.

Laney K. Jones, Dave L Dixon, T. A. Jacobson, 2022, Journal of clinical lipidology.

Familial Hypercholesterolemia in the Electronic Medical Records and Genomics Network: Prevalence, Penetrance, Cardiovascular Risk, and Outcomes After Return of Results

Laney K. Jones, David C. Kochan, W. Chung, 2023, Circulation. Genomic and precision medicine.

Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk Reduction

Laney K. Jones, Dustin N. Hartzel, J. Peterson, 2022, Circulation. Genomic and precision medicine.

How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?

Laney K. Jones, M. Sarkies, J. Pang, 2023, Current Atherosclerosis Reports.

Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit.

Laney K. Jones, Jennifer G. Robinson, Alan S. Brown, 2019, Journal of clinical lipidology.

Subtyping Severe Hypercholesterolemia by Genetic Determinant to Stratify Risk of Coronary Artery Disease

E. Sijbrands, S. Gidding, M. Oetjens, 2023, Arteriosclerosis, thrombosis, and vascular biology.

Genetic identification of familial hypercholesterolemia within a single U.S. health care system

Dustin N. Hartzel, D. Ledbetter, F. Dewey, 2016, Science.

Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach

Laney K. Jones, R. Brownson, A. Goldberg, 2023, Frontiers in Health Services.

Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States.

Laney K. Jones, J. Peterson, D. Veenstra, 2022, Journal of clinical lipidology.

Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis

Laney K. Jones, Ilene G. Ladd, Nephi A. Walton, 2021, Circulation. Genomic and precision medicine.

Translating guidelines into practice via implementation science: an update in lipidology

Laney K. Jones, A. Sturm, M. Gionfriddo, 2022, Current opinion in lipidology.

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis

Laney K. Jones, Lauren H. Yaeger, Marc S. Williams, 2021, Implementation Science.

Healthcare Utilization and Patients’ Perspectives After Receiving a Positive Genetic Test for Familial Hypercholesterolemia: A Pilot Study

Laney K. Jones, S. Pendergrass, M. Murray, 2018, Circulation. Genomic and precision medicine.

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia

A. Sturm, A. Rahm, Emilie Simmons, 2023, BMC Health Services Research.

Understanding the medication prior-authorization process: A case study of patients and clinical staff from a large rural integrated health delivery system

Laney K. Jones, J. Graham, M. Gionfriddo, 2019, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Improving clinical practice guidelines with implementation science

Laney K. Jones, G. Watts, S. Gidding, 2021, Nature Reviews Cardiology.

Translating Evidence-based Approaches into optimal Care for individuals at High-risk of ASCVD: Pilot testing of case-based e-learning modules and design of the TEACH-ASCVD study.

N. Desai, D. Karalis, P. Kris-Etherton, 2023, Journal of clinical lipidology.

Evaluation of an educational strategy to improve medication reconciliation in ambulatory care.

Laney K. Jones, Katrina M. Romagnoli, J. Graham, 2021, Journal of the American Pharmacists Association : JAPhA.

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study

Laney K. Jones, Ilene G. Ladd, S. Gidding, 2021, Journal of personalized medicine.

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia

Laney K. Jones, M. Rich, C. Ballantyne, 2021, Journal of the American Heart Association.